BMO Capital Reiterates Outperform Following DAVIDsTEA Inc.'s (DTEA) In-Line 2Q
- Nasdaq, S&P stumble as Netflix, chip stocks drag; AmEx boosts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Wall St indexes split, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Jabil falls after placing CEO on paid leave amid internal investigation
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Pre-Open Stock Movers 09/08: (RPRX) (RAD) (JUNO) Higher; (GEVO) (NLST) (TSCO) (PIR) Lower (more...)
September 8, 2016 9:29 AM EDTToday's Pre-Open Movers
Repros Therapeutics Inc. (Nasdaq: RPRX) 31.9% HIGHER; provided posotive results of the first course of treatment from Repros ongoing study of Proellex® for the treatment of premenopausal women with confirmed symptomatic endometriosis.
Gevo, Inc. (Nasdaq: GEVO) 25.7% LOWER; announced that it intends to offer and sell, subject to market and other conditions,... More
After-Hours Stock Movers 09/07: (RPRX) (JUNO) (ABEO) Higher; (GEVO) (TSCO) (PIR) Lower (more...)
September 7, 2016 6:07 PM EDTToday's After-Hours Movers
Repros Therapeutics Inc. (Nasdaq: RPRX) 43.9% HIGHER; provided posotive results of the first course of treatment from Repros ongoing study of Proellex® for the treatment of premenopausal women with confirmed symptomatic endometriosis.
Gevo, Inc. (Nasdaq: GEVO) 17.2% LOWER; announced that it intends to offer and sell, subject to market and other conditions, Series E units, with each Series E unit consisting of one share of common stock and Series I... More
DAVIDsTEA Inc. (DTEA) Misses Q2 EPS by 2c, Offers Q3 Guidance
September 7, 2016 4:04 PM EDTDAVIDsTEA Inc. (NASDAQ: DTEA) reported Q2 EPS of (CDN$0.09), CDN$0.02 worse than the analyst estimate of (CDN$0.07). Revenue for the quarter came in at CDN$41.1 million versus the consensus estimate of CDN$30.93 million.
comparable sales increase of... More